Drugs / Bicanorm
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04321161 | Feb → Mar 2020 | acute myeloid leukemia | University of Freiburg | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bicanorm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04321161 ↗ |
| Known as | Sodium bicarbonate | “Bicanorm (Sodium bicarbonate)” NCT04321161 ↗ |